Subject | Gender | Age | FEV1% predicted | Baseline PC20 (mg/mL) | GSTM1 genotype | GSTT1 genotype |
---|---|---|---|---|---|---|
1 | F | 22 | 144 | >16 | Present | Null |
2 | F | 22 | 107 | 3.5 | N/A | N/A |
3 | F | 20 | 104 | 13.9 | Present | Null |
4 | F | 31 | 113 | >16 | Null | Null |
5 | F | 24 | 116 | >16 | Null | Null |
6 | M | 32 | 123 | >16 | Null | Null |
7 | F | 34 | 79 | 0.2 | Null | Present |
8 | M | 27 | 105 | >16 | Present | Present |
9 | F | 25 | 117 | >16 | Null | Null |
10 | M | 46 | 66 | 0.3 | Present | Null |
11 | M | 27 | 107 | >16 | Null | Present |
12 | F | 46 | 63 | >16 | Null | Present |
13 | F | 20 | 98 | 2.1 | Present | Present |
14 | F | 31 | 103 | 0.3 | Null | Null |
15 | M | 28 | 100 | >16 | Null | Present |
16 | M | 23 | 104 | 2.4 | Present | Present |
17 | F | 23 | 101 | >16 | Null | Present |
18 | M | 23 | 112 | >16 | Present | Present |
N/A refers to subject who did not consent to genotyping.
GST, glutathione-S-transferase; PC20, concentration of methacholine that reduces FEV1 20% from baseline.